Home

The effect of Denosumab, the inhibitor for receptor activator of nuclear factor kappa-B ligand (RANKL), on dinitrobenzensulfonic acid (DNBS)-induced experimental model of crohn's disease.

Files in this item

This item appears in the following Collection(s)

View Statistics